{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T21:47:05Z","timestamp":1787003225954,"version":"build-2736575974"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:00:00Z","timestamp":1758672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:00:00Z","timestamp":1758672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000060","name":"U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI150305"],"award-info":[{"award-number":["R01AI150305"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["5UL1TR002535-02S1"],"award-info":[{"award-number":["5UL1TR002535-02S1"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["P30CA046934"],"award-info":[{"award-number":["P30CA046934"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008086","name":"Global Down Syndrome Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008086","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["U24AG092191"],"award-info":[{"award-number":["U24AG092191"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Linda Crnic Institute for Down Syndrome, Anna and John J. Sie Foundation, GI & Liver Innate Immune Program, Human Immunology and Immunotherapy Initiative, University of Colorado School of Medicine."},{"name":"Linda Crnic Institute for Down Syndrome, Anna and John J. Sie Foundation, GI & Liver Innate Immune Program, Human Immunology and Immunotherapy Initiative, University of Colorado School of Medicine,"},{"DOI":"10.13039\/100005508","name":"Boettcher Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005508","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-63862-9","type":"journal-article","created":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T09:17:50Z","timestamp":1758705470000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["An integrated multi-omic natural history study of human development, sexual dimorphism, and the effects of trisomy 21"],"prefix":"10.1038","volume":"16","author":[{"given":"Neetha Paul","family":"Eduthan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micah G.","family":"Donovan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Araya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1150-3976","authenticated-orcid":false,"given":"Angela L.","family":"Rachubinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2725-0205","authenticated-orcid":false,"given":"Kelly D.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0485-3927","authenticated-orcid":false,"given":"Matthew D.","family":"Galbraith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9048-1941","authenticated-orcid":false,"given":"Joaquin M.","family":"Espinosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,24]]},"reference":[{"key":"63862_CR1","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3389\/fendo.2011.00095","volume":"2","author":"MO Savage","year":"2011","unstructured":"Savage, M. O., Hwa, V., David, A., Rosenfeld, R. G. & Metherell, L. A. Genetic defects in the growth hormone-IGF-I axis causing growth hormone insensitivity and impaired linear growth.Front. Endocrinol.2, 95 (2011).","journal-title":"Front. Endocrinol."},{"key":"63862_CR2","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3389\/fpubh.2017.00335","volume":"5","author":"E Jaul","year":"2017","unstructured":"Jaul, E. & Barron, J. Age-related diseases and clinical and public health implications for the 85\u2009years old and over population.Front. Public Health 5, 335 (2017).","journal-title":"Front. Public Health"},{"key":"63862_CR3","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1038\/nrm2944","volume":"11","author":"CR Burtner","year":"2010","unstructured":"Burtner, C. R. & Kennedy, B. K. Progeria syndromes and ageing: what is the connection?. Nat. Rev. Mol. cell Biol. 11, 567\u2013578 (2010).","journal-title":"Nat. Rev. Mol. cell Biol."},{"key":"63862_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fragi.2023.1327833","volume":"4","author":"F Milosic","year":"2023","unstructured":"Milosic, F., Hengstschlager, M. & Osmanagic-Myers, S. Premature aging in genetic diseases: what conclusions can be drawn for physiological aging. Front Aging 4, 1327833 (2023).","journal-title":"Front Aging"},{"key":"63862_CR5","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/s41576-019-0183-6","volume":"21","author":"D Melzer","year":"2020","unstructured":"Melzer, D., Pilling, L. C. & Ferrucci, L. The genetics of human ageing. Nat. Rev. Genet. 21, 88\u2013101 (2020).","journal-title":"Nat. Rev. Genet."},{"key":"63862_CR6","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nrg1871","volume":"7","author":"K Christensen","year":"2006","unstructured":"Christensen, K., Johnson, T. E. & Vaupel, J. W. The quest for genetic determinants of human longevity: challenges and insights. Nat. Rev. Genet. 7, 436\u2013448 (2006).","journal-title":"Nat. Rev. Genet."},{"key":"63862_CR7","first-page":"45","volume":"114","author":"E Ginter","year":"2013","unstructured":"Ginter, E. & Simko, V. Women live longer than men. Bratisl. Lek. Listy 114, 45\u201349 (2013).","journal-title":"Bratisl. Lek. Listy"},{"key":"63862_CR8","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.beem.2007.04.007","volume":"21","author":"JC Wells","year":"2007","unstructured":"Wells, J. C. Sexual dimorphism of body composition. Best. Pr. Res Clin. Endocrinol. Metab. 21, 415\u2013430 (2007).","journal-title":"Best. Pr. Res Clin. Endocrinol. Metab."},{"key":"63862_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-85402-3","volume":"11","author":"K Kleisner","year":"2021","unstructured":"Kleisner, K. et al. How and why patterns of sexual dimorphism in human faces vary across the world. Sci. Rep. 11, 5978 (2021).","journal-title":"Sci. Rep."},{"key":"63862_CR10","doi-asserted-by":"publisher","DOI":"10.1093\/pnasnexus\/pgae025","volume":"3","author":"AD Galinsky","year":"2024","unstructured":"Galinsky, A. D. et al. Are many sex\/gender differences really power differences?. PNAS Nexus 3, pgae025 (2024).","journal-title":"PNAS Nexus"},{"key":"63862_CR11","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1177\/1745691613484767","volume":"8","author":"AH Eagly","year":"2013","unstructured":"Eagly, A. H. & Wood, W. The nature-nurture debates: 25\u2009years of challenges in understanding the psychology of gender. Perspect. Psychol. Sci. 8, 340\u2013357 (2013).","journal-title":"Perspect. Psychol. Sci."},{"key":"63862_CR12","doi-asserted-by":"publisher","first-page":"e1001081","DOI":"10.1371\/journal.pbio.1001081","volume":"9","author":"S Baron-Cohen","year":"2011","unstructured":"Baron-Cohen, S. et al. Why are autism spectrum conditions more prevalent in males?. PLoS Biol. 9, e1001081 (2011).","journal-title":"PLoS Biol."},{"key":"63862_CR13","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3233\/JPD-191683","volume":"9","author":"S Cerri","year":"2019","unstructured":"Cerri, S., Mus, L. & Blandini, F. Parkinson\u2019s disease in women and men: what\u2019s the difference?. J. Parkinsons Dis. 9, 501\u2013515 (2019).","journal-title":"J. Parkinsons Dis."},{"key":"63862_CR14","doi-asserted-by":"publisher","DOI":"10.1590\/1414-431x2021e11711","volume":"55","author":"J Fabi\u00e3o","year":"2022","unstructured":"Fabi\u00e3o, J. et al. Why do men have worse COVID-19-related outcomes? A systematic review and meta-analysis with sex adjusted for age. Braz. J. Med. Biol. Res.55, e11711 (2022).","journal-title":"Braz. J. Med. Biol. Res."},{"key":"63862_CR15","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1503\/jpn.150205","volume":"40","author":"PR Albert","year":"2015","unstructured":"Albert, P. R. Why is depression more prevalent in women?. J. Psychiatry Neurosci. 40, 219\u2013221 (2015).","journal-title":"J. Psychiatry Neurosci."},{"key":"63862_CR16","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1177\/1756285613488434","volume":"6","author":"HF Harbo","year":"2013","unstructured":"Harbo, H. F., Gold, R. & Tintor\u00e9, M. Sex and gender issues in multiple sclerosis. Ther. Adv. Neurol. Disord. 6, 237\u2013248 (2013).","journal-title":"Ther. Adv. Neurol. Disord."},{"key":"63862_CR17","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1111\/eva.13167","volume":"14","author":"VL Kronzer","year":"2021","unstructured":"Kronzer, V. L., Bridges, S. L. Jr. & Davis, J. M. 3rd Why women have more autoimmune diseases than men: An evolutionary perspective. Evol. Appl. 14, 629\u2013633 (2021).","journal-title":"Evol. Appl."},{"key":"63862_CR18","first-page":"602","volume":"248","author":"J Lejeune","year":"1959","unstructured":"Lejeune, J., Gauthier, M. & Turpin, R. Human chromosomes in tissue cultures. C. R. Hebd. des. Seances Acad. Sci. 248, 602\u2013603 (1959).","journal-title":"C. R. Hebd. des. Seances Acad. Sci."},{"key":"63862_CR19","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41572-019-0143-7","volume":"6","author":"SE Antonarakis","year":"2020","unstructured":"Antonarakis, S. E. et al. Down syndrome. Nat. Rev. Dis. Prim. 6, 9 (2020).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"63862_CR20","doi-asserted-by":"crossref","unstructured":"Bull, M. J. et al. Health supervision for children and adolescents with Down syndrome. Pediatrics 149, e2022057010 (2022).","DOI":"10.1542\/peds.2022-057010"},{"key":"63862_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.621440","volume":"12","author":"T Illouz","year":"2021","unstructured":"Illouz, T. et al. Immune dysregulation and the increased risk of complications and mortality following respiratory tract infections in adults with down syndrome. Front. Immunol. 12, 621440 (2021).","journal-title":"Front. Immunol."},{"key":"63862_CR22","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1038\/gim.2016.23","volume":"18","author":"H Hasle","year":"2016","unstructured":"Hasle, H., Friedman, J. M., Olsen, J. H. & Rasmussen, S. A. Low risk of solid tumors in persons with Down syndrome. Genet. Med.18, 1151\u20131157 (2016).","journal-title":"Genet. Med."},{"key":"63862_CR23","doi-asserted-by":"publisher","first-page":"923","DOI":"10.3122\/jabfm.2020.06.190425","volume":"33","author":"V Fitzpatrick","year":"2020","unstructured":"Fitzpatrick, V., Rivelli, A., Bria, K. & Chicoine, B. Heart disease in adults with Down syndrome between 1996 and 2016. J. Am. Board Fam. Med 33, 923\u2013931 (2020).","journal-title":"J. Am. Board Fam. Med"},{"key":"63862_CR24","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1002\/alz.12112","volume":"16","author":"HM Snyder","year":"2020","unstructured":"Snyder, H. M. et al. Further understanding the connection between Alzheimer\u2019s disease and Down syndrome. Alzheimers Dement.16, 1065\u20131077 (2020).","journal-title":"Alzheimers Dement."},{"key":"63862_CR25","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adg6218","volume":"9","author":"MD Galbraith","year":"2023","unstructured":"Galbraith, M. D. et al. Multidimensional definition of the interferonopathy of Down syndrome and its response to JAK inhibition. Sci. Adv. 9, eadg6218 (2023).","journal-title":"Sci. Adv."},{"key":"63862_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2023.1132296","volume":"11","author":"D Shaki","year":"2023","unstructured":"Shaki, D. et al. GHRH-GH-IGF1 axis in pediatric Down syndrome: a systematic review and mini meta-analysis. Front. Pediatr. 11, 1132296 (2023).","journal-title":"Front. Pediatr."},{"key":"63862_CR27","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1038\/s41591-019-0673-2","volume":"25","author":"B Lehallier","year":"2019","unstructured":"Lehallier, B. et al. Undulating changes in human plasma proteome profiles across the lifespan. Nat. Med. 25, 1843\u20131850 (2019).","journal-title":"Nat. Med."},{"key":"63862_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114599","volume":"43","author":"MG Donovan","year":"2024","unstructured":"Donovan, M. G. et al. Multimodal analysis of dysregulated heme metabolism, hypoxic signaling, and stress erythropoiesis in Down syndrome. Cell Rep. 43, 114599 (2024).","journal-title":"Cell Rep."},{"key":"63862_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-32552-1","volume":"13","author":"D Saul","year":"2022","unstructured":"Saul, D. et al. A new gene set identifies senescent cells and predicts senescence-associated pathways across tissues. Nat. Commun. 13, 4827 (2022).","journal-title":"Nat. Commun."},{"key":"63862_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9570","volume":"6","author":"MJ Peters","year":"2015","unstructured":"Peters, M. J. et al. The transcriptional landscape of age in human peripheral blood. Nat. Commun. 6, 8570 (2015).","journal-title":"Nat. Commun."},{"key":"63862_CR31","first-page":"221","volume":"57","author":"R Seidl","year":"1999","unstructured":"Seidl, R. et al. Serotonin (5-HT) in brains of adult patients with Down syndrome. J. Neural Transm. Suppl. 57, 221\u2013232 (1999).","journal-title":"J. Neural Transm. Suppl."},{"key":"63862_CR32","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/S0140-6736(65)90454-X","volume":"2","author":"JB Tu","year":"1965","unstructured":"Tu, J. B. & Zellweger, H. Blood-serotonin deficiency in Down\u2019s syndrome. Lancet 2, 715\u2013716 (1965).","journal-title":"Lancet"},{"key":"63862_CR33","doi-asserted-by":"publisher","first-page":"e1465","DOI":"10.1542\/peds.2006-3448","volume":"120","author":"N Whittle","year":"2007","unstructured":"Whittle, N., Sartori, S. B., Dierssen, M., Lubec, G. & Singewald, N. Fetal Down syndrome brains exhibit aberrant levels of neurotransmitters critical for normal brain development. Pediatrics 120, e1465\u2013e1471 (2007).","journal-title":"Pediatrics"},{"key":"63862_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12739-9","volume":"10","author":"RK Powers","year":"2019","unstructured":"Powers, R. K. et al. Trisomy 21 activates the kynurenine pathway via increased dosage of interferon receptors. Nat. Commun. 10, 4766 (2019).","journal-title":"Nat. Commun."},{"key":"63862_CR35","doi-asserted-by":"crossref","unstructured":"Rachubinski, A. L. et al. JAK inhibition decreases the autoimmune burden in Down syndrome. Elife 13, RP99323 (2024).","DOI":"10.7554\/eLife.99323.3"},{"key":"63862_CR36","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s41588-023-01627-0","volume":"56","author":"JP de Magalh\u00e3es","year":"2024","unstructured":"de Magalh\u00e3es, J. P. Distinguishing between driver and passenger mechanisms of aging. Nat. Genet. 56, 204\u2013211 (2024).","journal-title":"Nat. Genet."},{"key":"63862_CR37","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.cell.2014.10.039","volume":"159","author":"BK Kennedy","year":"2014","unstructured":"Kennedy, B. K. et al. Geroscience: linking aging to chronic disease. Cell 159, 709\u2013713 (2014).","journal-title":"Cell"},{"key":"63862_CR38","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1038\/nrg2415","volume":"9","author":"C Ober","year":"2008","unstructured":"Ober, C., Loisel, D. A. & Gilad, Y. Sex-specific genetic architecture of human disease. Nat. Rev. Genet. 9, 911\u2013922 (2008).","journal-title":"Nat. Rev. Genet."},{"key":"63862_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14396-9","volume":"11","author":"EJ M\u00e1rquez","year":"2020","unstructured":"M\u00e1rquez, E. J. et al. Sexual-dimorphism in human immune system aging. Nat. Commun. 11, 751 (2020).","journal-title":"Nat. Commun."},{"key":"63862_CR40","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S2213-8587(21)00346-6","volume":"10","author":"N Bechmann","year":"2022","unstructured":"Bechmann, N. et al. Sexual dimorphism in COVID-19: potential clinical and public health implications. Lancet Diabetes Endocrinol. 10, 221\u2013230 (2022).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"63862_CR41","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1002\/bdr2.1589","volume":"111","author":"CT Mai","year":"2019","unstructured":"Mai, C. T. et al. National population-based estimates for major birth defects, 2010-2014. Birth Defects Res. 111, 1420\u20131435 (2019).","journal-title":"Birth Defects Res."},{"key":"63862_CR42","doi-asserted-by":"publisher","unstructured":"Huang, C. et al. Models for evaluation of biological age based on multi-omics. bioRxiv https:\/\/doi.org\/10.1101\/2021.12.13.472382 (2021).","DOI":"10.1101\/2021.12.13.472382"},{"key":"63862_CR43","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1038\/s43587-024-00692-2","volume":"4","author":"X Shen","year":"2024","unstructured":"Shen, X. et al. Nonlinear dynamics of multi-omics profiles during human aging. Nat. Aging 4, 1619\u20131634 (2024).","journal-title":"Nat. Aging"},{"key":"63862_CR44","doi-asserted-by":"crossref","unstructured":"Sciarra, F., Campolo, F., Franceschini, E., Carlomagno, F. & Venneri, M. A. Gender-specific impact of sex hormones on the immune system. Int. J. Mol. Sci. 24, 6302 (2023).","DOI":"10.3390\/ijms24076302"},{"key":"63862_CR45","doi-asserted-by":"crossref","unstructured":"Robinson, G. A. et al. Sex hormones drive changes in lipoprotein metabolism. iScience 24, 103257 (2021).","DOI":"10.1016\/j.isci.2021.103257"},{"key":"63862_CR46","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s00109-021-02169-w","volume":"100","author":"C Ferreira","year":"2022","unstructured":"Ferreira, C. et al. Sexual dimorphism in cardiac remodeling: the molecular mechanisms ruled by sex hormones in the heart. J. Mol. Med. (Berl., Ger.) 100, 245\u2013267 (2022).","journal-title":"J. Mol. Med. (Berl., Ger.)"},{"key":"63862_CR47","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1196\/annals.1365.035","volume":"1092","author":"DJ Hadjidakis","year":"2006","unstructured":"Hadjidakis, D. J. & Androulakis, I. I. Bone remodeling. Ann. N. Y. Acad. Sci. 1092, 385\u2013396 (2006).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"63862_CR48","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s00109-020-01890-2","volume":"98","author":"A Moreira-Pais","year":"2020","unstructured":"Moreira-Pais, A. et al. Sex differences on adipose tissue remodeling: from molecular mechanisms to therapeutic interventions. J. Mol. Med.98, 483\u2013493 (2020).","journal-title":"J. Mol. Med."},{"key":"63862_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.steroids.2023.109306","volume":"199","author":"J Rizk","year":"2023","unstructured":"Rizk, J., Sahu, R. & Duteil, D. An overview on androgen-mediated actions in skeletal muscle and adipose tissue. Steroids 199, 109306 (2023).","journal-title":"Steroids"},{"key":"63862_CR50","doi-asserted-by":"publisher","first-page":"R125","DOI":"10.1530\/EJE-17-0124","volume":"177","author":"L Schiffer","year":"2017","unstructured":"Schiffer, L., Kempegowda, P., Arlt, W. & O\u2019Reilly, M. W. MECHANISMS IN ENDOCRINOLOGY: the sexually dimorphic role of androgens in human metabolic disease. Eur. J. Endocrinol. 177, R125\u2013R143 (2017).","journal-title":"Eur. J. Endocrinol."},{"key":"63862_CR51","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.cellimm.2015.02.004","volume":"294","author":"A Trigunaite","year":"2015","unstructured":"Trigunaite, A., Dimo, J. & J\u00f8rgensen, T. N. Suppressive effects of androgens on the immune system. Cell Immunol. 294, 87\u201394 (2015).","journal-title":"Cell Immunol."},{"key":"63862_CR52","first-page":"635","volume":"6","author":"D Khan","year":"2015","unstructured":"Khan, D. & Ansar Ahmed, S. The immune system is a natural target for estrogen action: opposing effects of estrogen in two prototypical autoimmune diseases. Front. Immunol. 6, 635 (2015).","journal-title":"Front. Immunol."},{"key":"63862_CR53","doi-asserted-by":"crossref","unstructured":"Waugh, K. A. et al. Triplication of the interferon receptor locus contributes to hallmarks of Down syndrome in a mouse model. Nat. Genet. 55, 1034\u22121047 (2023).","DOI":"10.1038\/s41588-023-01399-7"},{"key":"63862_CR54","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s10875-020-00803-9","volume":"40","author":"XF Kong","year":"2020","unstructured":"Kong, X. F. et al. Three copies of four interferon receptor genes underlie a mild type I interferonopathy in down syndrome. J. Clin. Immunol. 40, 807\u2013819 (2020).","journal-title":"J. Clin. Immunol."},{"key":"63862_CR55","doi-asserted-by":"crossref","unstructured":"Sullivan, K. D. et al. Trisomy 21 consistently activates the interferon response. Elife 5, e16220 (2016).","DOI":"10.7554\/eLife.16220"},{"key":"63862_CR56","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-13858-3","volume":"7","author":"KD Sullivan","year":"2017","unstructured":"Sullivan, K. D. et al. Trisomy 21 causes changes in the circulating proteome indicative of chronic autoinflammation. Sci. Rep. 7, 14818 (2017).","journal-title":"Sci. Rep."},{"key":"63862_CR57","doi-asserted-by":"publisher","unstructured":"Chorvinsky, E. et al. Down Syndrome Alters Type-III IFN and Pro-Inflammatory Airway Epithelial Responses to RSV Infection. Am. J. Resp. Cell Molecul. Biol. https:\/\/doi.org\/10.1165\/rcmb.2025-0068OC (2025).","DOI":"10.1165\/rcmb.2025-0068OC"},{"key":"63862_CR58","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2019.154938","volume":"127","author":"D Huggard","year":"2020","unstructured":"Huggard, D. et al. Increased systemic inflammation in children with Down syndrome. Cytokine 127, 154938 (2020).","journal-title":"Cytokine"},{"key":"63862_CR59","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.jdcr.2019.02.007","volume":"5","author":"AL Rachubinski","year":"2019","unstructured":"Rachubinski, A. L. et al. Janus kinase inhibition in Down syndrome: 2 cases of therapeutic benefit for alopecia areata. JAAD Case Rep. 5, 365\u2013367 (2019).","journal-title":"JAAD Case Rep."},{"key":"63862_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108407","volume":"33","author":"KD Tuttle","year":"2020","unstructured":"Tuttle, K. D. et al. JAK1 Inhibition blocks lethal immune hypersensitivity in a mouse model of down syndrome. Cell Rep. 33, 108407 (2020).","journal-title":"Cell Rep."},{"key":"63862_CR61","doi-asserted-by":"crossref","unstructured":"Pham, A. T. et al. JAK inhibition for treatment of psoriatic arthritis in Down syndrome. Rheumatology 60, e309\u2212e311 (2021).","DOI":"10.1093\/rheumatology\/keab203"},{"key":"63862_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2024.578442","volume":"395","author":"AL Rachubinski","year":"2024","unstructured":"Rachubinski, A. L. et al. JAK inhibition in Down syndrome regression disorder. J. Neuroimmunol. 395, 578442 (2024).","journal-title":"J. Neuroimmunol."},{"key":"63862_CR63","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.neuroscience.2016.11.017","volume":"341","author":"K Switon","year":"2017","unstructured":"Switon, K., Kotulska, K., Janusz-Kaminska, A., Zmorzynska, J. & Jaworski, J. Molecular neurobiology of mTOR. Neuroscience 341, 112\u2013153 (2017).","journal-title":"Neuroscience"},{"key":"63862_CR64","doi-asserted-by":"crossref","unstructured":"Takei, N. & Nawa, H. mTOR signaling and its roles in normal and abnormal brain development. Front. Mol. Neurosci. 7, 28 (2014).","DOI":"10.3389\/fnmol.2014.00028"},{"key":"63862_CR65","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.12659\/MSM.893377","volume":"21","author":"R Malak","year":"2015","unstructured":"Malak, R., Kostiukow, A., Krawczyk-Wasielewska, A., Mojs, E. & Samborski, W. Delays in motor development in children with Down syndrome. Med Sci. Monit. 21, 1904\u20131910 (2015).","journal-title":"Med Sci. Monit."},{"key":"63862_CR66","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1097\/YCO.0000000000000307","volume":"30","author":"R Hithersay","year":"2017","unstructured":"Hithersay, R., Hamburg, S., Knight, B. & Strydom, A. Cognitive decline and dementia in Down syndrome. Curr. Opin. Psychiatry 30, 102\u2013107 (2017).","journal-title":"Curr. Opin. Psychiatry"},{"key":"63862_CR67","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","volume":"139","author":"JP Thiery","year":"2009","unstructured":"Thiery, J. P., Acloque, H., Huang, R. Y. & Nieto, M. A. Epithelial-mesenchymal transitions in development and disease. Cell 139, 871\u2013890 (2009).","journal-title":"Cell"},{"key":"63862_CR68","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1161\/CIRCRESAHA.111.259960","volume":"110","author":"A von Gise","year":"2012","unstructured":"von Gise, A. & Pu, W. T. Endocardial and epicardial epithelial to mesenchymal transitions in heart development and disease. Circ. Res. 110, 1628\u20131645 (2012).","journal-title":"Circ. Res."},{"key":"63862_CR69","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1161\/CIRCULATIONAHA.122.059706","volume":"147","author":"K Dimopoulos","year":"2023","unstructured":"Dimopoulos, K. et al. Cardiovascular complications of Down syndrome: scoping review and expert consensus. Circulation 147, 425\u2013441 (2023).","journal-title":"Circulation"},{"key":"63862_CR70","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-018-0834-8","volume":"19","author":"N Rout-Pitt","year":"2018","unstructured":"Rout-Pitt, N., Farrow, N., Parsons, D. & Donnelley, M. Epithelial mesenchymal transition (EMT): a universal process in lung diseases with implications for cystic fibrosis pathophysiology. Resp. Res. 19, 136 (2018).","journal-title":"Resp. Res."},{"key":"63862_CR71","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49781-1","volume":"15","author":"MG Donovan","year":"2024","unstructured":"Donovan, M. G. et al. Variegated overexpression of chromosome 21 genes reveals molecular and immune subtypes of Down syndrome. Nat. Commun. 15, 5473 (2024).","journal-title":"Nat. Commun."},{"key":"63862_CR72","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.nbt.2011.11.016","volume":"29","author":"L Gold","year":"2012","unstructured":"Gold, L., Walker, J. J., Wilcox, S. K. & Williams, S. Advances in human proteomics at high scale with the SOMAscan proteomics platform. N. Biotechnol. 29, 543\u2013549 (2012).","journal-title":"N. Biotechnol."},{"key":"63862_CR73","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/978-1-4939-9236-2_2","volume":"1978","author":"T Nemkov","year":"2019","unstructured":"Nemkov, T., Reisz, J. A., Gehrke, S., Hansen, K. C. & D\u2019Alessandro, A. High-throughput metabolomics: isocratic and gradient mass spectrometry-based methods. Methods Mol. Biol. 1978, 13\u201326 (2019).","journal-title":"Methods Mol. Biol."},{"key":"63862_CR74","doi-asserted-by":"crossref","unstructured":"Clasquin, M. F., Melamud, E. & Rabinowitz, J. D. LC-MS data processing with MAVEN: a metabolomic analysis and visualization engine. Curr. Protoc. Bioinform. 14, Unit14 11 (2012).","DOI":"10.1002\/0471250953.bi1411s37"},{"key":"63862_CR75","unstructured":"GBIF. R: A Language and Environment for Statistical Computing. https:\/\/www.gbif.org\/tool\/81287\/r-a-language-and-environment-for-statistical-computing (2020)."},{"key":"63862_CR76","unstructured":"RStudio. RStudio: Integrated Development for R. https:\/\/www.r-project.org\/conferences\/useR-2011\/abstracts\/180111-allairejj.pdf (2022)."},{"key":"63862_CR77","unstructured":"ggforce. Accelerating \u2018ggplot2\u2019. https:\/\/ggforce.data-imaginist.com\/ (2019)."},{"key":"63862_CR78","doi-asserted-by":"crossref","unstructured":"Wickham, H. ggplot2: Elegant Graphics for Data Analysis 2nd edn (Springer-Verlag New York, 2016).","DOI":"10.1007\/978-3-319-24277-4_9"},{"key":"63862_CR79","doi-asserted-by":"publisher","first-page":"e0185056","DOI":"10.1371\/journal.pone.0185056","volume":"12","author":"B Bushnell","year":"2017","unstructured":"Bushnell, B., Rood, J. & Singer, E. BBMerge - Accurate paired shotgun read merging via overlap. PLoS ONE 12, e0185056 (2017).","journal-title":"PLoS ONE"},{"key":"63862_CR80","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/s41587-019-0201-4","volume":"37","author":"D Kim","year":"2019","unstructured":"Kim, D., Paggi, J. M., Park, C., Bennett, C. & Salzberg, S. L. Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype. Nat. Biotechnol. 37, 907\u2013915 (2019).","journal-title":"Nat. Biotechnol."},{"key":"63862_CR81","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li, H. et al. The sequence alignment\/map format and SAMtools. Bioinformatics 25, 2078\u20132079 (2009).","journal-title":"Bioinformatics"},{"key":"63862_CR82","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","volume":"31","author":"S Anders","year":"2015","unstructured":"Anders, S., Pyl, P. T. & Huber, W. HTSeq-a python framework to work with high-throughput sequencing data. Bioinformatics 31, 166\u2013169 (2015).","journal-title":"Bioinformatics"},{"key":"63862_CR83","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"63862_CR84","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/cyto.a.22271","volume":"83","author":"R Finck","year":"2013","unstructured":"Finck, R. et al. Normalization of mass cytometry data with bead standards. Cytom. A 83, 483\u2013494 (2013).","journal-title":"Cytom. A"},{"key":"63862_CR85","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/nprot.2015.020","volume":"10","author":"ER Zunder","year":"2015","unstructured":"Zunder, E. R. et al. Palladium-based mass tag cell barcoding with a doublet-filtering scheme and single-cell deconvolution algorithm. Nat. Protoc. 10, 316\u2013333 (2015).","journal-title":"Nat. Protoc."},{"key":"63862_CR86","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/bioinformatics\/btt703","volume":"30","author":"A Kramer","year":"2014","unstructured":"Kramer, A., Green, J., Pollard, J. Jr. & Tugendreich, S. Causal analysis approaches in Ingenuity Pathway Analysis. Bioinformatics 30, 523\u2013530 (2014).","journal-title":"Bioinformatics"},{"key":"63862_CR87","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"63862_CR88","doi-asserted-by":"publisher","unstructured":"Sergushichev, A. A. An algorithm for fast preranked gene set enrichment analysis using cumulative statistic calculation. bioRxiv https:\/\/doi.org\/10.1101\/060012 (2016).","DOI":"10.1101\/060012"},{"key":"63862_CR89","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon, A. et al. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst. 1, 417\u2013425 (2015).","journal-title":"Cell Syst."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-63862-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-63862-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-63862-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T09:17:59Z","timestamp":1758705479000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-63862-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,24]]},"references-count":89,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["63862"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-63862-9","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,24]]},"assertion":[{"value":"21 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.M.E. has provided consulting services to Eli Lilly and Co., Gilead Sciences Inc., Biohaven Pharmaceuticals, and Perha Pharmaceuticals. All other authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8346"}}